49th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170348324 | DERIVATIVES OF BETULIN | 2017-12-07 |
20170348325 | OXYTOCIN RECEPTOR ANTAGONIST THERAPY IN THE LUTEAL PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES | 2017-12-07 |
20170348326 | NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS | 2017-12-07 |
20170348327 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | 2017-12-07 |
20170348328 | Abiraterone Acetate Formulation and Methods of Use | 2017-12-07 |
20170348329 | Combination Drug Therapy | 2017-12-07 |
20170348330 | ANTIVIRAL COMPOUND AND ANALOGUES THEREOF FOR TREATMENT OR PREVENTION OF FLAVIVIRUS DENGUE/ZIKA INFECTIONS | 2017-12-07 |
20170348331 | METHODS AND COMPOSITIONS FOR MODULATING SEROTONIN LEVELS | 2017-12-07 |
20170348332 | SALICYLATE COMPOUND COMPOSITION | 2017-12-07 |
20170348333 | DRY POWDER FORMULATIONS FOR INHALATION | 2017-12-07 |
20170348334 | PROCESSES FOR THE PREPARATION OF AMORPHOUS TENOFOVIR ALAFENAMIDE HEMIFUMARATE AND A PREMIX THEREOF | 2017-12-07 |
20170348335 | Physiologically Balanced Injectable Formulations of Fosnetupitant | 2017-12-07 |
20170348336 | METHOD OF TREATING MELANOMA USING AN INHIBITOR OF AN ATYPICAL PROTEIN KINASE C | 2017-12-07 |
20170348337 | MULTIFUNCTIONAL MEMBRANE-ACTIVE AMINOGLYCOSIDE-PEPTIDE CONJUGATES | 2017-12-07 |
20170348338 | TREATMENT OF INFLAMMATORY CONDITIONS BY MODULATION OF HYALURONAN AND HYALURONIDASE ACTIVITY | 2017-12-07 |
20170348339 | COMPOSITIONS AND METHOD OF USE OF A-TYPE PROCYANIDINS | 2017-12-07 |
20170348340 | NEW C-GLYCOSYLPOLYPHENOL ANTIDIABETIC AGENTS, EFFECT ON GLUCOSE TOLERANCE AND INTERACTION WITH BETA-AMYLOID. THERAPEUTIC APPLICATIONS OF THE SYNTHESIZED AGENT(S) AND OF GENISTA TENERA ETHYL ACETATE EXTRACTS CONTAINING SOME OF THOSE AGENTS | 2017-12-07 |
20170348341 | Metronomic Oral Gemcitabine for Cancer Therapy | 2017-12-07 |
20170348342 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C VIRUS | 2017-12-07 |
20170348343 | METHODS OF TREATING HEPATITIS E VIRAL INFECTION | 2017-12-07 |
20170348344 | AQUEOUS OPHTHALMIC SOLUTION | 2017-12-07 |
20170348345 | Combination Therapy For Cancer | 2017-12-07 |
20170348346 | COMBINATION THERAPIES FOR INNER EAR SENSORY HAIR CELL REGENERATION/REPLACEMENT | 2017-12-07 |
20170348347 | AGENT FOR IMPROVING OCULAR SUBJECTIVE SYMPTOMS AND METHOD THEREOF | 2017-12-07 |
20170348348 | METHODS FOR IMPROVING LUNG CONDITION AND AIRWAY | 2017-12-07 |
20170348349 | Modulation of Amyloid Beta Toxicity and Processing By Xenon Gas | 2017-12-07 |
20170348350 | Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | 2017-12-07 |
20170348351 | DRUG BASED ON MAGHEMITE FOR SIMULTANEOUS REDUCTION OF GASTROINTESTINAL SODIUM RESORPTION AND PHOSPHATE RESORPTION | 2017-12-07 |
20170348352 | Zinc Phosphate Complex | 2017-12-07 |
20170348353 | FLOWABLE TISSUE MATRICES | 2017-12-07 |
20170348354 | LYOPHILIZED PLATELET LYSATES | 2017-12-07 |
20170348355 | LYOPHILIZED PLATELET LYSATES | 2017-12-07 |
20170348356 | MICROVESICLES (MVS) DERIVED FROM ADULT STEM CELLS FOR USE IN THE THERAPEUTIC TREATMENT OF A TUMOR DISEASE | 2017-12-07 |
20170348357 | TAU PROTEIN PRODUCTION ACCELERATOR, AND THERAPEUTIC OR PREVENTIVE AGENT AND THERAPEUTIC OR PREVENTIVE FOOD COMPOSITION FOR DISEASES CAUSED BY TAU PROTEIN DEFICIENCY | 2017-12-07 |
20170348358 | Compositions and Methods for the Treatment of Hepatic Diseases and Disorders | 2017-12-07 |
20170348359 | Method and System for Treating Cancer and Other Age-Related Diseases by Extending the Healthspan of a Human | 2017-12-07 |
20170348360 | Compositions and Methods for Treating Inflammatory Bowel Diseases (IBDs) and Other Disorders | 2017-12-07 |
20170348361 | PROBIOTIC AUGMENTATION OF ANTI-TUMOR ENDOTHELIUM IMMUNE RESPONSES | 2017-12-07 |
20170348362 | ANTHELMINTIC PROBIOTIC COMPOSITIONS AND METHODS | 2017-12-07 |
20170348363 | IMMUNE MODULATION FOR ISCHEMIA DISEASE AND ACCELERATION OF RECOVERY AFTER ISCHEMIC EVENTS BY MICROBIOME STIMULATED T REGULATORY CELLS | 2017-12-07 |
20170348364 | PROCESS FOR THE MANUFACTURE OF PATHOGEN INHIBITING BACTERIA | 2017-12-07 |
20170348365 | NOVEL ENTEROPATHOGENIC E. COLI BACTERIOPHAGE ESC-CHP-2 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROPATHOGENIC E. COLI | 2017-12-07 |
20170348366 | METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME | 2017-12-07 |
20170348367 | USE OF HELMINTHOSTACHYS ZEYLANICA, UGONINS OR FLAVONE-BASED COMPOUNDS FOR THE TREATMENT OR PREVENTION OF METABOLIC DISEASES | 2017-12-07 |
20170348368 | Medicinal Composition of Extract of Seed of Emblica Officinalis and Method of Preparing the Same | 2017-12-07 |
20170348369 | Plant Extract and Its Therapeutic Use | 2017-12-07 |
20170348370 | SOYBEAM SEED EXTRACT, METHOD FOR PRODUCING THE SAME AND USES THEREOF | 2017-12-07 |
20170348371 | THE ANTI CANCEROUS, ANTIPARASITE (TOXOPLASMA GONDII (PROTOZOON) AND ANTIMICROBIAL EFFECT AND DOSAGE OF NIGELLA (NIGELLA SATIVA) EXTRACT | 2017-12-07 |
20170348372 | ACNE-REMOVING TRADITIONAL CHINESE MEDICINE COMPOSITION AND PREPARATION METHOD THEREOF | 2017-12-07 |
20170348373 | COMPOSITION COMPRISING CAFFEOYLSHIKIMIC ACIDS, PROTOCATECHUIC ACID, HYDROXYTYROSOL, HYDROXYBENZOIC ACID AND THEIR DERIVATIVES AND METHOD OF PREPARATION THEREOF | 2017-12-07 |
20170348374 | ANTI CANCEROUS, ANTIPARASITE (TOXOPLASMA GONDII (PROTOZON) AND ANTIMICROBIAL EFFECT AND DOSAGE OF GINGER (ZINGIBER OFFICINALE) EXTRACT | 2017-12-07 |
20170348375 | DISLODGEMENT AND RELEASE OF HSC FROM THE BONE MARROW STEM CELL NICHE USING ALPHA9 INTEGRIN ANTAGONISTS | 2017-12-07 |
20170348376 | TUBULYSIN CONJUGATE FOR USE IN TREATING CANCER | 2017-12-07 |
20170348377 | COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING | 2017-12-07 |
20170348378 | METHODS OF TREATING LUNG INFECTION WITH CASPOFUNGIN | 2017-12-07 |
20170348379 | METHODS AND SYSTEMS FOR DELIVERY OF ZW1 HEPTAPEPTIDE | 2017-12-07 |
20170348380 | INTRAARTICULAR APPLICATION OF PEPSTATIN IN THE CASE OF ARTHROSIS | 2017-12-07 |
20170348381 | FORMULATION | 2017-12-07 |
20170348382 | LYOPHILIZED INJECTABLE COMPOSITIONS OF DAPTOMYCIN | 2017-12-07 |
20170348383 | NOVEL COMBINATION AND USE | 2017-12-07 |
20170348384 | Treatment of Rhinosinusitis with P-glycoprotein Inhibitors | 2017-12-07 |
20170348385 | GLYCOPEPTIDE COMPOSITIONS | 2017-12-07 |
20170348386 | METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES | 2017-12-07 |
20170348387 | AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY | 2017-12-07 |
20170348388 | ADJUVANTS USEFUL FOR STIMULATION OF IMMUNITY TO TUMOR ENDOTHELIAL CELLS | 2017-12-07 |
20170348389 | TREATING LIVER DISEASES WITH INTERLEUKIN 24 | 2017-12-07 |
20170348390 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2017-12-07 |
20170348391 | MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERS | 2017-12-07 |
20170348392 | SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES | 2017-12-07 |
20170348393 | TREATMENT OF CNS INFLAMMATORY DISORDERS | 2017-12-07 |
20170348394 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A STATISTICAL CO-POLYAMINO ACID | 2017-12-07 |
20170348395 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid | 2017-12-07 |
20170348396 | Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals | 2017-12-07 |
20170348397 | Serum Albumin-Binding Fibronectin Type III Domains | 2017-12-07 |
20170348398 | COMPOSITIONS AND METHODS FOR DECREASING BLOOD GLUCAGON LEVELS | 2017-12-07 |
20170348399 | NOVEL PROTEIN MATERIAL | 2017-12-07 |
20170348400 | METHODS AND COMPOSITIONS FOR ENHANCING AN IMMUNE RESPONSE, BLOCKING MONOCYTE MIGRATION, AMPLIFYING VACCINE IMMUNITY AND INHIBITING TUMOR GROWTH AND METASTASIS | 2017-12-07 |
20170348401 | GAS-FILLED MICROVESICLES FOR USE AS VACCINE | 2017-12-07 |
20170348402 | SYSTEM AND METHOD FOR DELIVERING GENETIC MATERIAL OR PROTEIN TO CELLS | 2017-12-07 |
20170348403 | ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN | 2017-12-07 |
20170348404 | VACCINATION METHODS | 2017-12-07 |
20170348405 | MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES | 2017-12-07 |
20170348406 | Subunit Immersion Vaccines for Fish | 2017-12-07 |
20170348407 | STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS | 2017-12-07 |
20170348408 | PURIFICATION OF STREPTOCOCCAL CAPSULAR POLYSACCHARIDE | 2017-12-07 |
20170348409 | COMPOSITIONS AND METHODS RELATED TO VIRAL VACCINES | 2017-12-07 |
20170348410 | HPV EPITOPES TARGETED BY T CELLS INFILTRATING CERVICAL MALIGNANCIES FOR USE IN VACCINES | 2017-12-07 |
20170348411 | IMPROVED METHODS FOR ENTEROVIRUS INACTIVATION, ADJUVANT ADSORPTION AND DOSE REDUCED VACCINE COMPOSITIONS OBTAINED THEREOF | 2017-12-07 |
20170348412 | METHOD FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN | 2017-12-07 |
20170348413 | INFLUENZA H5 VACCINES | 2017-12-07 |
20170348414 | NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES | 2017-12-07 |
20170348415 | TOLEROGENIC COMPOSITIONS AND METHODS | 2017-12-07 |
20170348416 | TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS | 2017-12-07 |
20170348417 | TREATMENT OF ATTENTION DEFICIT DISORDERS AND ASSOCIATED SYMPTOMS | 2017-12-07 |
20170348418 | Foamable Vehicle and Pharmaceutical Compositions Thereof | 2017-12-07 |
20170348419 | ORAL LIQUID SUSPENSIONS | 2017-12-07 |
20170348420 | Solid Pharmaceutical Compositions Containing Pregabalin | 2017-12-07 |
20170348421 | ITRACONAZOLE COMPOSITIONS AND DOSAGE FORMS, AND METHODS OF USING THE SAME | 2017-12-07 |
20170348422 | SILVESTROL ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | 2017-12-07 |
20170348423 | Injectable solution at pH 7 comprising at least one basal insulin the pl of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals | 2017-12-07 |